Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Brenner

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Clinical Oncology|October 1, 1983
Phase II study of vinblastine in advanced refractory ovarian carcinomaW W Grosh, D E Brenner, H W Jones, et al.
The Journal of Biological Chemistry|November 25, 1987
The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps. A correlative study of cardiac muscle with isolated membrane fractionsR J Boucek, R D Olson, D E Brenner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 21, 2021
Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New NormalA Shaukat, T L Marsh, S D Crockett, et al.
Surgical Oncology|August 1, 1995
Pharmacokinetic evaluation of percutaneous hepatic venous isolation for administration of regional chemotherapyD A August, N Verma, M A Vaerten, et al.
Cancer Research|June 15, 1987
Effect of allyl alcohol-induced sublethal hepatic damage upon doxorubicin metabolism and toxicity in the rabbitD E Brenner, L B Anthony, S Halter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbitsN L Harris, D E Brenner, L B Anthony, et al.
British Journal of Cancer|March 1, 2002
Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapyI Shureiqi, S B Cantor, S M Lippman, et al.
Melanoma Research|October 24, 2002
Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesisI Winer, D P Normolle, I Shureiqi, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Surrogate endpoint biomarkers for cervical cancer chemopreventive trialsM T Ruffin, M S Ogaily, C M Johnston, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbitB J Cusack, D A Tesnohlidek, V L Loseke, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Oncology|October 1, 1983
Phase II study of vinblastine in advanced refractory ovarian carcinomaW W Grosh, D E Brenner, H W Jones, et al.
The Journal of Biological Chemistry|November 25, 1987
The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps. A correlative study of cardiac muscle with isolated membrane fractionsR J Boucek, R D Olson, D E Brenner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 21, 2021
Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New NormalA Shaukat, T L Marsh, S D Crockett, et al.
Surgical Oncology|August 1, 1995
Pharmacokinetic evaluation of percutaneous hepatic venous isolation for administration of regional chemotherapyD A August, N Verma, M A Vaerten, et al.
Cancer Research|June 15, 1987
Effect of allyl alcohol-induced sublethal hepatic damage upon doxorubicin metabolism and toxicity in the rabbitD E Brenner, L B Anthony, S Halter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbitsN L Harris, D E Brenner, L B Anthony, et al.
British Journal of Cancer|March 1, 2002
Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapyI Shureiqi, S B Cantor, S M Lippman, et al.
Melanoma Research|October 24, 2002
Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesisI Winer, D P Normolle, I Shureiqi, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Surrogate endpoint biomarkers for cervical cancer chemopreventive trialsM T Ruffin, M S Ogaily, C M Johnston, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbitB J Cusack, D A Tesnohlidek, V L Loseke, et al.
Pageof 9